Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 mars 2026 15h17 HE | Source: Robbins LLP

Robbins LLP Urges INO Stockholders Who Lost Money Investing in Inovio Pharmaceuticals, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
05 mars 2026 14h55 HE | Source: Robbins LLP

Robbins LLP Urges KD Stockholders Who Lost Money Investing in Kyndryl Holdings, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Kyndryl Holdings, Inc. (KD) Materially Misstated its Financial Statements
05 mars 2026 14h21 HE | Source: Robbins LLP

POM Class Action: POMDoctor Ltd. Stockholders with Large Losses Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is Investigating Allegations that POMDoctor Ltd. (POM) was the Subject of a Pump-and-Dump Scheme
04 mars 2026 14h22 HE | Source: Robbins LLP

Robbins LLP Urges PMI Stockholders to Contact the Firm for Information About the Class Action Against Picard Medical, Inc.

Robbins LLP is Investigating Allegations that Picard Medical, Inc. (PMI) was the Subject of a Fraudulent Stock Promotion Scheme
04 mars 2026 13h40 HE | Source: Robbins LLP

Robbins LLP Urges MREO Stockholders to Contact the Firm for Information About the Class Action Against Mereo BioPharma Group plc

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
04 mars 2026 13h14 HE | Source: Robbins LLP

Robbins LLP Urges RARE Stockholders to Contact the Firm for Information About the Class Action Against Ultragenyx Pharmaceutical Inc.

Robbins LLP is Investigating Allegations that Ultragenyx Pharmaceutical Inc. (RARE) Misled Investors Regarding Phase III Orbit and Cosmic Studies
02 mars 2026 20h23 HE | Source: Robbins LLP

Robbins LLP Reminds BBWI Stockholders of the March 16, 2026 Lead Plaintiff Deadline – Contact the Firm Today for Information About Leading the Bath & Body Works, Inc. Class Action

Robbins LLP is Investigating Allegations that Bath & Body Works, Inc. (BBWI) Misled Investors Regarding its Business Strategy
02 mars 2026 20h08 HE | Source: Robbins LLP

Robbins LLP Reminds CRWV Stockholders of the March 13, 2026 Lead Plaintiff Deadline – Contact the Firm Today for Information About Leading the CoreWeave, Inc. Class Action

Robbins LLP is Investigating Allegations that CoreWeave, Inc. (CRWV) Misled Investors Regarding its Ability to Accommodate Customer Demand
02 mars 2026 16h07 HE | Source: Robbins LLP

LAKE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Lakeland Industries, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Lakeland Industries, Inc. (LAKE) Misled Investors Regarding the Integration of Recent Acquisitions
02 mars 2026 16h06 HE | Source: Robbins LLP

SNOW Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Snowflake Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Snowflake Inc. (SNOW) Misled Investors Regarding its Business Prospects

Page suivante